Evidence map›Paper›PMID 34781677›Full record

ArticleInorganic chemistry2021

Intermediate Cu(II)-Thiolate Species in the Reduction of Cu(II)GHK by Glutathione: A Handy Chelate for Biological Cu(II) Reduction.

Iwona Ufnalska, Simon C Drew, Igor Zhukov, Kosma Szutkowski, Urszula E Wawrzyniak, Wojciech Wróblewski, Tomasz Frączyk, Wojciech Bal

Open access · hybridAbstract read
In one paragraph

Article in Inorganic chemistry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Copper-Induced Stimulation of Ectophosphatase Activity ofPathogens (Basel, Switzerland) · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Bifunctional Peptide Nanofibrils for Targeted Protein Degradation.Angewandte Chemie (International ed. in English) · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Iwona UfnalskaChair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, Warsaw 00-664, Poland.
Simon C DrewDepartment of Medicine (Royal Melbourne Hospital), The University of Melbourne, Victoria 3010, Australia.ORCID https://orcid.org/0000-0002-1459-9865
Igor ZhukovPolish Academy of Sciences Institute of Biochemistry and Biophysics, Pawińskiego 5a, Warsaw 02-106, Poland.ORCID https://orcid.org/0000-0002-9912-1018
Kosma SzutkowskiNanoBioMedical Centre, Adam Mickiewicz University, Wszechnicy Piastowskiej 3, Poznań 61-614, Poland.ORCID https://orcid.org/0000-0002-6091-9049
Urszula E WawrzyniakChair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, Warsaw 00-664, Poland.
Wojciech WróblewskiChair of Medical Biotechnology, Faculty of Chemistry, Warsaw University of Technology, Noakowskiego 3, Warsaw 00-664, Poland.
Tomasz FrączykPolish Academy of Sciences Institute of Biochemistry and Biophysics, Pawińskiego 5a, Warsaw 02-106, Poland.ORCID https://orcid.org/0000-0003-2084-3446
Wojciech BalPolish Academy of Sciences Institute of Biochemistry and Biophysics, Pawińskiego 5a, Warsaw 02-106, Poland.ORCID https://orcid.org/0000-0003-3780-083X
Institute of Biochemistry and Biophysics, Polish Academy of Sciences · PLWarsaw University of Technology · PLAdam Mickiewicz University in Poznań · PLThe Royal Melbourne Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gly-His-Lys (GHK) is a tripeptide present in the human bloodstream that exhibits a number of biological functions. Its activity is attributed to the copper-complexed form, Cu(II)GHK. Little is known, however, about the molecular aspects of the mechanism of its action. Here, we examined the reaction of Cu(II)GHK with reduced glutathione (GSH), which is the strongest reductant naturally occurring in human plasma. Spectroscopic techniques (UV-vis, CD, EPR, and NMR) and cyclic voltammetry helped unravel the reaction mechanism. The impact of temperature, GSH concentration, oxygen access, and the presence of ternary ligands on the reaction were explored. The transient GSH-Cu(II)GHK complex was found to be an important reaction intermediate. The kinetic and redox properties of this complex, including tuning of the reduction rate by ternary ligands, suggest that it may provide a missing link in copper trafficking as a precursor of Cu(I) ions, for example, for their acquisition by the CTR1 cellular copper transporter.

Indexed as

Coordination ComplexesCopperGlutathioneHumansMolecular StructureOligopeptidesOxidation-ReductionSulfhydryl CompoundsCoordination ComplexesCopperGlutathioneOligopeptidesSulfhydryl Compounds

Identifiers

PMID34781677
PMCPMC8653159
OpenAlexW3214311594

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.